shutterstock 390538711 6b3c40fdd32742caa54307db3553cab1
|

Scientists achieve breakthrough in the treatment of ‘neglected’ polymyalgia rheumatica

shutterstock 390538711 6b3c40fdd32742caa54307db3553cab1

Scientists have had success treating a ‘neglected’ inflammatory disease, polymyalgia rheumatica, with a drug that could offer patients an alternative to steroids.

The study, conducted by Anglia Ruskin University (ARU) and published in the New England Journal of Medicine, describes a successful trial of sarilumab. The drug, approved in Britain to treat rheumatoid arthritis, blocked the protein interleukin-6, which can cause inflammation.

Polymyalgia rheumatica (PMR) is characterized by pain and morning stiffness in the shoulder and hips and affects people over the age of 50. It can significantly affect quality of life and is currently mainly treated with the steroids glucocorticoids.

Although glucocorticoids can control the condition, more than half of PMR patients experience a relapse of their condition when they reduce their steroid medication. Interleukin-6 has been implicated in the pathophysiology of PMR because circulating elevated levels and increased tissue expression of interleukin-6 have been found in PMR patients.

During the year-long clinical trial conducted by researchers, 118 patients received either twice-monthly injections of sarilumab or a placebo. The sarilumab group received a tapering dose of glucocorticoid for 14 weeks in combination with bimonthly injections of sarilumab, while the placebo group received a tapering dose of glucocorticoid for 52 weeks.

The primary outcome at the end of the study was sustained remission of the condition. This happened in 28% of people taking sarilumab, compared to 10% of people taking the placebo. After achieving remission at 12 weeks, there were more disease flares in the placebo group (57%) compared to those who received sarilumab (24%).

Lead PMR expert and senior author of the study, Professor Bhaskar Dasgupta, from the Medical Technology Research Center at Anglia Ruskin University (ARU), said: “Polymyalgia rheumatica is a poorly managed and neglected condition for which current treatment is unsatisfactory and can have long-term side effects. Patients can relapse while tapering their medications, and these relapses currently have very limited treatment options.

“Our findings show promise that sarilumab can be used to treat PMR and improve outcomes for people coming off steroid medications.

“This is an exciting development that has the potential to improve treatment options for a condition common in older people. PMR is the most common reason for long-term steroid prescriptions. Any effective drug that can spare the use of steroids would be a should have a major impact.” on reducing the serious side effects of such steroids, including diabetes, osteoporotic fractures and infections.”

The research was funded by Sanofi and Regeneron Pharmaceuticals.

Earlier this year, a review paper was published in the journal Nature reviews by Professor Dasgupta and colleagues highlighted the emerging view that relapsed PMR patients also have underlying giant cell arteritis, in which the main blood vessel aorta and its branches become inflamed. Researchers suggested that the two should be treated as linked conditions under the term GCA-PMR Spectrum Disease (GPSD).

Source:

Magazine reference:

Tomelleri, A., et al. (2023). Disease stratification in GCA and PMR: state of the art and future perspectives. Nature Reviews Rheumatology. doi.org/10.1038/s41584-023-00976-8.

Source link

Similar Posts

  • CTL Amedica will present the MONDRIAN™ ALIF system at the University of Miami on November 4

      Spine surgeons and distributors are welcome DALLAS, November 3, 2023 / OrthoSpineNews/ – On November 4, CTL Amedica will introduce surgeons and distributors to the new MONDRIAN™ Anterior Lumbar Interbody Fusion (ALIF) System during a special hands-on laboratory. The laboratory will be held in the Minimally Invasive Surgical Training and Education Center, located in…

  • |

    Anti-TNF-α therapy induced psoriasis in patients with rheumatoid arthritis according to FDA postmarketing surveillance data

      FDA Adverse Event Reporting System (FAERS) The United States Food and Drug Administration Adverse Event Reporting System (FAERS) is a data repository that collects voluntary drug-related reports from healthcare professionals, consumers, and legal representatives. In cases where the adverse reaction (AE) is reported to the manufacturer, the manufacturer is required to forward the report…

  • |

    Antidepressants, osteoporosis and psychiatry: Dr.Aruna Tummala

      Can your antidepressants, especially SSRIsbe a hidden culprit behind it weakening of bones and osteoporosisespecially when you are navigating postmenopause? What is it exactly “holistic psychiatry”, and how could it revolutionize your understanding of mental health? Want to know which of your favorite foods are silent undermining your bones and mental clarity? Dive into…

  • |

    Foods to avoid with knee arthritis

    What if the key to managing your joint pain isn’t found in a medicine cabinet, but in your kitchen? Recent health data shows about 1 in 5 adults in the United States live with arthritis. This chronic condition affects daily life in profound ways. Dr. Ajul Shah, a board-certified surgeon, notes that arthritis can make simple tasks like climbing stairs a significant challenge for patients. We believe the connection between what you eat and how you feel is powerful. Your daily diet directly impacts your overall health and long-term quality of life. knee arthritis diet Managing your nutrition is a foundational step for anyone seeking better joint function and comfort. This guide provides actionable information. Our goal is to help you make smarter nutritional choices to support your mobility. Key Takeaways Arthritis is a common condition that significantly impacts daily activities and mobility. Diet plays a crucial role in managing inflammation and joint health. Simple daily tasks can become challenging for people with chronic joint pain. Proactive nutritional choices are a key part of improving long-term quality of life. Understanding which dietary items may worsen symptoms is an empowering step for patients. A targeted approach to eating can help regain control over physical comfort. Introduction The journey to easing joint stiffness often begins with a closer look at what’s on your plate. We see nutrition as a foundational element for managing chronic conditions. Dr. Ajul Shah, a board-certified surgeon, provides a key insight. While there is no cure for most types of arthritis, diet remains a powerful tool for managing symptoms. This perspective shifts the focus. It empowers individuals to take an active role in their comfort. Overview of Joint Pain and Diet What you consume directly influences the pain and stiffness many people experience. Specific items can trigger inflammatory responses in the body. Understanding this link is essential. It allows for smarter daily choices that minimize discomfort. overview of joint pain and diet connection Our approach examines how certain selections can either worsen or soothe persistent joint issues. Small, consistent changes in your routine lead to significant improvements in well-being. The table below outlines common dietary factors and their general effects. Dietary Factor Potential Impact on Joints Practical Management Tip Highly Processed Foods May increase systemic inflammation Opt for whole, single-ingredient items Sugary Snacks and Drinks Can promote stiffness and swelling Choose fruits for natural sweetness High-Fat Dairy Products Might aggravate pain for some individuals Experiment with plant-based alternatives We provide insights into turning knowledge into action. The goal is better mobility and a higher quality of life through informed eating. Understanding Knee Arthritis and Inflammation Think of inflammation not just as swelling, but as a key biological signal that directly dictates your mobility and comfort. Dr. Ajul Shah notes this process is a primary factor in joint damage and the resulting pain for many patients. understanding knee arthritis and inflammation Chronic inflammation within the body acts like a constant alarm. It restricts movement and can accelerate the progression of this joint disease. How Inflammation Affects Joint Mobility Your immune system’s response to certain triggers leads to swelling and stiffness. This is a hallmark of arthritis symptoms….

  • |

    Who participates in youth sports?

      Organized sports participation among children aged 6–17 years: United States, 2020 Black LI, Terlizzi EP, Vahratian A. National Center for Health Statistics (US). Publication date: 08/11/2022. Series: data overview; No. 441 https://stacks.cdc.gov/view/cdc/119026 Take home message Sports participation was lower among racial and ethnic minority children, children whose parents had lower education or income, children…

Leave a Reply

Your email address will not be published. Required fields are marked *